I read this article on web md and I am sharing it here.
http://www.webmd.com/ibs/news/20150...=llSQeWmuAxO5z4RWkiBTLBXFE73IOX1cy/n5jmCB7jc=
May 28, 2015 -- The FDA has approved two new prescription medications to treat irritable bowel syndrome with diarrhea, or IBS-D. It’s the latest step in a years-long struggle to find safe and effective treatments for the condition.
“I think patients with IBS should be very excited to have more options,” says Lawrence Schiller, MD, program director of the gastroenterology fellowship at Baylor University Medical Center. “Neither drug is a miracle, but they are both likely to be helpful for some patients.”
The two medications are Viberzi (eluxadoline) and Xifaxan (rifaximin). Viberzi helps you have fewer bowel contractions, which leads to less diarrhea. Xifaxan is an antibiotic that’s thought to work by changing your gut bacteria and reducing diarrhea.
Irritable bowel syndrome (IBS) is estimated to affect up to 15% of Americans, or more than 45 million people, according to the National Institutes of Health. But only about half of those people have gotten diagnosed with the condition by a doctor. IBS affects about twice as many women as men, and it most often happens in those under age 45.
There are several types of it. In IBS-D, diarrhea is the main symptom. Other types include IBS-C, in which constipation is the main symptom, and mixed IBS, where constipation and diarrhea alternate.
http://www.webmd.com/ibs/news/20150...=llSQeWmuAxO5z4RWkiBTLBXFE73IOX1cy/n5jmCB7jc=
May 28, 2015 -- The FDA has approved two new prescription medications to treat irritable bowel syndrome with diarrhea, or IBS-D. It’s the latest step in a years-long struggle to find safe and effective treatments for the condition.
“I think patients with IBS should be very excited to have more options,” says Lawrence Schiller, MD, program director of the gastroenterology fellowship at Baylor University Medical Center. “Neither drug is a miracle, but they are both likely to be helpful for some patients.”
The two medications are Viberzi (eluxadoline) and Xifaxan (rifaximin). Viberzi helps you have fewer bowel contractions, which leads to less diarrhea. Xifaxan is an antibiotic that’s thought to work by changing your gut bacteria and reducing diarrhea.
Irritable bowel syndrome (IBS) is estimated to affect up to 15% of Americans, or more than 45 million people, according to the National Institutes of Health. But only about half of those people have gotten diagnosed with the condition by a doctor. IBS affects about twice as many women as men, and it most often happens in those under age 45.
There are several types of it. In IBS-D, diarrhea is the main symptom. Other types include IBS-C, in which constipation is the main symptom, and mixed IBS, where constipation and diarrhea alternate.
